Skip to content

Public FDA record

Z-1274-2018: SporAmpule Biological Indicator Catalog Number SPS5-100

Recall record Z-1274-2018 for Mesa Laboratories Bozeman Manufacturing Facility. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-1274-2018
Company in FDA record
Mesa Laboratories Bozeman Manufacturing Facility
FDA record creation date
Mar 29, 2018
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

The concentration of bromocresol purple in the recalled lots does not conform to specification.

Source facts

Action
Per the Recall Strategy, consignees have been requested to immediately discontinue use and discard according to site procedures.
Initiated
2018-02-12
Root cause
Other
Terminated
2018-07-03
Distribution
United States, Republic of Korea, Israel, Poland, France, China, Canada, Japan, Singapore, Hong Kong, Jordan
Recall number
Z-1274-2018
Recall status
Terminated
CDRH record ID
162162
FDA record created
2018-03-29
Recall event number
79374

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗